Michael Vishal Jaglal
Advertisement
Articles by Michael Vishal Jaglal
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Ziftomenib Plus 7+3 Yields High Response Rates in Newly Diagnosed AML
2
Pirtobrutinib Plus Venetoclax/Rituximab Improves PFS in Pretreated CLL
3
Sonrotoclax Plus Zanubrutinib Achieves >90% uMRD in Treatment-Naive CLL/SLL
4
Liso-Cel Demonstrates Real-World Efficacy in Relapsed/Refractory MCL
5